Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Onyx Pharmaceuticals Inc ONXX

Healthcare Biotechnology
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ONXX)

Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer

PR Newswire October 1, 2013

Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx

PR Newswire September 18, 2013

Onyx Pharmaceuticals Announces Data Presentations at 2013 European Cancer Congress

Marketwired September 17, 2013

WeissLaw LLP Files a Class Action Lawsuit Challenging the Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. -- ONXX

Globe Newswire August 30, 2013

Bayer's Stivarga® (regorafenib) Tablets Approved in Europe

PR Newswire August 30, 2013

ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Onyx Pharmaceuticals, Inc.

PR Newswire August 29, 2013

Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Amgen Inc.

Business Wire August 28, 2013

Rigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. Buyout

Business Wire August 27, 2013

Ryan & Maniskas, LLP Announces Investigation of Onyx Pharmaceuticals, Inc.

PR Newswire August 27, 2013
View More News ››

Opinion & Analysis (NDAQ:ONXX)

Stock picks including a coal play

J.W. Cotton November 4, 2009
View More Opinion ››

Bullboard Posts (NDAQ:ONXX)

Business-Update-Call

Interesting comments at Conference call [url=http://www.earningsimpact.com/Transcript/81410/ONXX/Business-Update-Call]read here[/url]
EarningsImpact1 - July 22, 2013

down on good news

briefing.com,  market wired,  cnbc  and a couple others today - really positive articles today about trial results...
imtesty - June 3, 2013

Exit Laws

css> ...
stockscores0 - July 4, 2006

Selling on Good News = buy at 27.29

Selling on Good News = buy at 27.29 People are so weird
OMEGA5 - May 16, 2005

hey mo

looks like you got your wish
bullet14 - March 22, 2000
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. provides contract drilling services, primarily to the oil and gas industry, in Canada and the United ...
View More »